https://www.selleckchem.com/pr....oducts/ripasudil-k-1
02). Furthermore, TT genotype was associated with more severe lesions compared with the CC + CT genotypes (TT vs. CC + CT for atrophy P = 0.07; for intestinal metaplasia P = 0.01; for moderate-to-severe lesions P = 0.01). OLGA and OLGIM stages III-IV were observed more frequently in patients with TT genotype compared with CC + CT genotypes (for OLGA P = 0.003; for OLGIM P = 0.036). The MTHFR 677C T TT genotype showed an increased risk of moderate-to-severe lesions by OLGA and OLGIM stages, and these results indicate that MT